Measles, Mumps, and Rubella Virus Vaccine, Live (Merck & Co)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles, Mumps, and Rubella Virus Vaccine, Live (Merck & Co)
Drug Alias NameM-M-RVaxProM-M-R II
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMumpsMeasles +[4] 
Global Approved IndicationsRubellaMumpsMeasles
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1978/01/01
Country/TerritoryUnited StatesSwitzerlandEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of ZurichMerck Sharp & Dohme BvMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active IndicationsRubellaMumpsMeasles
Inactive IndicationsChickenpox

Other Information

ATC CodeJ07BD52
Related LinksN/A